scholarly journals Petrographical, petrochemical characteristics of Hòn Rồng massif granitoids, Cam Ranh, Khánh Hòa

2020 ◽  
Vol 3 (3) ◽  
pp. 195-212
Author(s):  
Nguyen Kim Hoang ◽  
Lam Van Phuong
Keyword(s):  
Biotite Granite ◽  
Accessory Mineral ◽  
Chemical Compositions ◽  
Phase 2 ◽  
Phase 3 ◽  
Fine Grained ◽  
South Vietnam ◽  
High K ◽  
Ore Minerals ◽  
Absolute Height

Hòn Rồng massif granitoid has a high mountainous terrain, with an absolute height of 728 m, relatively equal, slightly extended in the Northwest-Southeast direction, occupying an area of ​​about 29 km2. Petrographical composition is mainly medium - grained biotite granite (phase 2), minor is fine- grained biotite granite (phase 3), vein rocks are aplite granite and pegmatite and  a little of xenolith of granodiorite in medium - grained biotite granite. Medium-grained biotite granite: major mineral composition (%): plagioclase (oligoclase) 25–35, quartz 30, orthoclas 25, biotite 5 - 8 and few hornblend; fine-grained granite (%): plagioclase (oligoclase) 30 - 35; quartz 30 - 35; feldspar kali (orthoclase, and microclin) 30, biotite 3 - 5; accessory mineral is zircon, orthite, apatite, sphen, and very little ore minerals (about ​​2%); epimagmatic minerals including: chlorite, epidot, kaolinite, sericite, carbonate, sausorite-replaced association. Rocks are altered alkalization strongly (albitization and microlinization), and minor are chloritization, epidotization and sericitization. Averaged chemical compositions (%)SiO2: 69.07–72.07; total alkali(K2O+Na2O) 7.35–7.96. Ratio of K2O/Na2O 1.04, low TiO2 (0.24–0.37). Ratios of A/CNK 1.02–1.09, Rb/Sr: 0.27–1.62; Ba/Sr: 1.82–2.56, Ba/Rb: 1.58–7.13; K/Rb: 0.42–0.62; Ca/Sr: 0.21–0.47; the value of Eu anomalies is low. Granite belongs to calc-alkaline, aluminum content is from medium to high; K-Na alkaline series, I-granite type. Granitoid had been formed in plutonic - volcanic arc of subduction-zone. Compared with the granitoid formations in South Vietnam territory, Hòn Rồng massif granitoid belongs to phase 2 (main) and phase 3 (minor) of Đèo Cả complex with late Kreta age.

scholarly journals Petrology and mineralogy of the Ulaan Del Zr-Nb-REE deposit, Lake Zone, Western Mongolia

2020 ◽  
Vol 50 ◽  
pp. 45-62
Author(s):  
Sanjsuren Oyunbat
Keyword(s):  
Fine Grained ◽  
Late Cambrian ◽  
Hydrothermal Processes ◽  
Western Mongolia ◽  
Lake Zone ◽  
High K ◽  
Ore Minerals ◽  
Type Granite ◽  
Host Rocks ◽  
Syenite Porphyry

The Ulaan Del deposit is located in the Lake Zone, Western Mongolia. In the area, middle-late Devonian alkali dykes of the Khalzan Complex are hosted in the middle-late Cambrian granodiorite-tonalite of the Togthohiinshil Complex. The alkali dykes of the Khalzan complex comprise medium- to fine-grained syenite, microsyenite, syenite-porphyry and trachyte, trachyrhyolite, and trachyandesite. The dykes are replaced to silica, sericite, albite, fluorite and are brecciated. They crosscut by quartz and quartz-carbonate veinlets. The dykes contain zircon (>0.19% Zr) with a total of rare earth elements oxides >0.1%. The host rocks of the Togtokhiinshil complex are mid-K, metaluminous, I- type granite, depleted in HFSE. Based on geochemical and mineralogical data, economic REE mineralization is concentrated in syenite and syenite porphyry of calc-alkaline high K to shoshonite series of A- type granite, emplaced at within a plate setting. Syenite dykes are enriched in REE. Ore minerals are zircon, apatite, sphene, monazite, xenotime, synchysite, parisite, fluorite and REE complex minerals, pyrite, rutile and limonite. Magmatic, metasomatic and hydrothermal processes significantly contributed to the formation of Zr, Nb, REE and Y mineralization at the Ulaan Del deposit.

scholarly journals Petrographical, petrochemical characteristics of Ta Kou massif granitoids, Ham Thuan Nam, Binh Thuan

2020 ◽  
Vol 4 (1) ◽  
pp. First
Author(s):  
Nguyen Thi Thu Thuy ◽  
Nguyen Kim Hoang
Keyword(s):  
Trace Elements ◽  
Chemical Composition ◽  
Potassium Feldspar ◽  
Biotite Granite ◽  
Total Alkalinity ◽  
Magmatic Activity ◽  
High Potassium ◽  
Fine Grained ◽  
Altered Granite ◽  
South Vietnam

Ta Kou is an isometric shape with an area of ​​about 15 km2. Petrographical composition is mainly biotite-hornblende granodiorite; minors are altered light-colored fine-grained biotite granite. Mineral composition is mainly plagioclase 45–50, quartz 25, potassium feldspar 15–20, biotite 5–10, hornblende (5–7); secondary is pyroxen; Accessory minerals include zircon, apatite, orthit, muscovite and rare ore. In some places, near fault or high arch of massif, rocks have been altered by other magma, especially near faults due to post-magma activity including fine-grained biotite granite which caused strongly by alkalization such as increasing the content of potassium felspar (35–50%) and quartz 30; reducing plagioclase content (30–25%); amphibole -colored minerals is rare, and pyroxene is absent. Chemical composition of medium acid granodiorite SiO2 61.08–62.14 (61.85); total alkalinity (K2O+Na2O) 5,99–6,04 (6.00); ratio of alkaline K2O/Na2O: 0.74-0.77 (0.75 <1). Characterized trace elements content of granodiorite: Rb and Ba are low but Sr is quite high; ratios Rb/Sr: 0.24; Ba/Sr 1.40, Ba/Rb: 5.85; K/Rb: 245.39; La/Yb: 10.33; Ce/Yb: 22.11; normal Eu anomalies. When influencing the post-magmatic activity, some granite is more acidific, the chemical composition of altered granite SiO2 72.27–74.07 (73.17); total alkalinity (K2O+Na2O): 7.48–7.96 (7.72); the ratio of alkaline  K2O/Na2O: 1.60–1.69 (1.64>1). Characterized trace elements content of altered granite: Ba and Sr are low but high Rb; ratios of Rb/Sr: 1.43; Ba/Sr: 3.06, Ba/Rb: 2.79; K/Rb: 218.05; La/Yb: 8.60 and Ce/Yb: 15.74; strong Eu anomalies.Ta Kou granitoids belong to the medium to high aluminum series, medium to high potassium alkaline series, negative Eu anomalies are from normal to strong, type of I- granite. Granitoid characterized subduction-related formation and altered, which may be due to the effects of later phase magmatic activity. Compared with granitoid formations in South Vietnam, Ta Kou massif granitoids belong to phase 2 of Định Quán complex.  

TEM/AEM characterization of fine-grained clay minerals in very-low-grade rocks: Evaluation of contamination by empa involving celadonite family minerals

1996 ◽  
Vol 54 ◽  
pp. 694-695
Author(s):  
Gejing Li ◽  
D. R. Peacor ◽  
D. S. Coombs ◽  
Y. Kawachi
Keyword(s):  
Electron Microscopy ◽  
Volcanic Rocks ◽  
Analytical Electron Microscopy ◽  
Metamorphic Rocks ◽  
New Mineral ◽  
Chemical Compositions ◽  
Low Grade ◽  
Fine Grained ◽  
Depth Analysis ◽  
Mineral Aggregates

Recent advances in transmission electron microscopy (TEM) and analytical electron microscopy (AEM) have led to many new insights into the structural and chemical characteristics of very finegrained, optically homogeneous mineral aggregates in sedimentary and very low-grade metamorphic rocks. Chemical compositions obtained by electron microprobe analysis (EMPA) on such materials have been shown by TEM/AEM to result from beam overlap on contaminant phases on a scale below resolution of EMPA, which in turn can lead to errors in interpretation and determination of formation conditions. Here we present an in-depth analysis of the relation between AEM and EMPA data, which leads also to the definition of new mineral phases, and demonstrate the resolution power of AEM relative to EMPA in investigations of very fine-grained mineral aggregates in sedimentary and very low-grade metamorphic rocks.Celadonite, having end-member composition KMgFe3+Si4O10(OH)2, and with minor substitution of Fe2+ for Mg and Al for Fe3+ on octahedral sites, is a fine-grained mica widespread in volcanic rocks and volcaniclastic sediments which have undergone low-temperature alteration in the oceanic crust and in burial metamorphic sequences.

Idalopirdin bei Alzheimererkrankung: nicht besser als Plazebo

2018 ◽  
Vol 86 (08) ◽  
pp. 456-457
Keyword(s):  
Phase 2 ◽  
Phase 3 ◽  
Alzheimer Demenz

Die Blockade von Serotoninrezeptoren, insbesondere des Serotonin-Rezeptortyps 5-HT6, als Zusatztherapie in Kombination mit Cholinesterasehemmer, hat in experimentellen Versuchen sowie in einer Phase-2-Studie positive Effekte bei Demenz gezeigt. Im Rahmen eines Phase-3 Entwicklungsprogramms wurde nun die Effektivität des selektiven Serotoninrezeptor-Antagonisten Idalopirdin bei leichter bis mittelschwerer Alzheimer Demenz geprüft.

PENERAPAN MODEL QUANTUM LEARNING UNTUK MENINGKATKAN HASIL BELAJAR AUTOCAD SISWA KELAS X TEKNIK PEMESINAN SMK NEGERI 1 STABAT

2013 ◽  
Vol 5 (1) ◽  
Author(s):  
Abdul Hasan Saragih
Keyword(s):  
Positive Response ◽  
Phase 1 ◽  
First Grade ◽  
Learning Model ◽  
Second Phase ◽  
Phase 2 ◽  
Phase 3 ◽  
The Third ◽  
Third Phase ◽  
Quantum Learning

This classroom research was conducted on the autocad instructions to the first grade of mechinary class of SMK Negeri 1 Stabat aiming at : (1) improving the student’ archievementon autocad instructional to the student of mechinary architecture class of SMK Negeri 1 Stabat, (2) applying Quantum Learning Model to the students of mechinary class of SMK Negeri 1 Stabat, arising the positive response to autocad subject by applying Quantum Learning Model of the students of mechinary class of SMK Negeri 1 Stabat. The result shows that (1) by applying quantum learning model, the students’ achievement improves significantly. The improvement ofthe achievement of the 34 students is very satisfactory; on the first phase, 27 students passed (70.59%), 10 students failed (29.41%). On the second phase 27 students (79.41%) passed and 7 students (20.59%) failed. On the third phase 30 students (88.24%) passed and 4 students (11.76%) failed. The application of quantum learning model in SMK Negeri 1 Stabat proved satisfying. This was visible from the activeness of the students from phase 1 to 3. The activeness average of the students was 74.31% on phase 1,81.35% on phase 2, and 83.63% on phase 3. (3) The application of the quantum learning model on teaching autocad was very positively welcome by the students of mechinary class of SMK Negeri 1 Stabat. On phase 1 the improvement was 81.53% . It improved to 86.15% on phase 3. Therefore, The improvement ofstudent’ response can be categorized good.

The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies

2017 ◽  
Vol 1 ◽  
pp. s49
Author(s):  
Linda Stein Gold ◽  
Sunil Dhawan ◽  
Jonathan Weiss ◽  
Zoe D Draelos ◽  
Herman Ellman
Keyword(s):  
Acne Vulgaris ◽  
Pooled Analysis ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Phase 3

Abstract Not Available

Clinical Drug Development for the Treatment of Pulmonary Arterial Hypertension: Collaboration With the Pharmaceutical Industry and Regulatory Agencies

2010 ◽  
Vol 9 (4) ◽  
pp. 214-219
Author(s):  
Robyn J. Barst
Keyword(s):  
Clinical Trials ◽  
Pulmonary Arterial Hypertension ◽  
Drug Development ◽  
Phase 1 ◽  
Preclinical Studies ◽  
Phase 2 ◽  
Phase 3 ◽  
Preclinical Testing ◽  
New Drug ◽  
Pulmonary Arterial

Drug development is the entire process of introducing a new drug to the market. It involves drug discovery, screening, preclinical testing, an Investigational New Drug (IND) application in the US or a Clinical Trial Application (CTA) in the EU, phase 1–3 clinical trials, a New Drug Application (NDA), Food and Drug Administration (FDA) review and approval, and postapproval studies required for continuing safety evaluation. Preclinical testing assesses safety and biologic activity, phase 1 determines safety and dosage, phase 2 evaluates efficacy and side effects, and phase 3 confirms efficacy and monitors adverse effects in a larger number of patients. Postapproval studies provide additional postmarketing data. On average, it takes 15 years from preclinical studies to regulatory approval by the FDA: about 3.5–6.5 years for preclinical, 1–1.5 years for phase 1, 2 years for phase 2, 3–3.5 years for phase 3, and 1.5–2.5 years for filing the NDA and completing the FDA review process. Of approximately 5000 compounds evaluated in preclinical studies, about 5 compounds enter clinical trials, and 1 compound is approved (Tufts Center for the Study of Drug Development, 2011). Most drug development programs include approximately 35–40 phase 1 studies, 15 phase 2 studies, and 3–5 pivotal trials with more than 5000 patients enrolled. Thus, to produce safe and effective drugs in a regulated environment is a highly complex process. Against this backdrop, what is the best way to develop drugs for pulmonary arterial hypertension (PAH), an orphan disease often rapidly fatal within several years of diagnosis and in which spontaneous regression does not occur?

scholarly journals Tenecteplase Thrombolysis for Acute Ischemic Stroke

Stroke ◽  
2020 ◽  
Vol 51 (11) ◽  
pp. 3440-3451
Author(s):  
Steven J. Warach ◽  
Adrienne N. Dula ◽  
Truman J. Milling
Keyword(s):  
Ischemic Stroke ◽  
Intracranial Hemorrhage ◽  
Time Window ◽  
Large Vessel ◽  
Bolus Administration ◽  
Phase 2 ◽  
Qualitative Synthesis ◽  
Phase 3 ◽  
Symptomatic Intracranial Hemorrhage ◽  
Meta Analyses

Tenecteplase is a fibrinolytic drug with higher fibrin specificity and longer half-life than the standard stroke thrombolytic, alteplase, permitting the convenience of single bolus administration. Tenecteplase, at 0.5 mg/kg, has regulatory approval to treat ST-segment–elevation myocardial infarction, for which it has equivalent 30-day mortality and fewer systemic hemorrhages. Investigated as a thrombolytic for ischemic stroke over the past 15 years, tenecteplase is currently being studied in several phase 3 trials. Based on a systematic literature search, we provide a qualitative synthesis of published stroke clinical trials of tenecteplase that (1) performed randomized comparisons with alteplase, (2) compared different doses of tenecteplase, or (3) provided unique quantitative meta-analyses. Four phase 2 and one phase 3 study performed randomized comparisons with alteplase. These and other phase 2 studies compared different tenecteplase doses and effects on early outcomes of recanalization, reperfusion, and substantial neurological improvement, as well as symptomatic intracranial hemorrhage and 3-month disability on the modified Rankin Scale. Although no single trial prospectively demonstrated superiority or noninferiority of tenecteplase on clinical outcome, meta-analyses of these trials (1585 patients randomized) point to tenecteplase superiority in recanalization of large vessel occlusions and noninferiority in disability-free 3-month outcome, without increases in symptomatic intracranial hemorrhage or mortality. Doses of 0.25 and 0.4 mg/kg have been tested, but no advantage of the higher dose has been suggested by the results. Current clinical practice guidelines for stroke include intravenous tenecteplase at either dose as a second-tier option, with the 0.25 mg/kg dose recommended for large vessel occlusions, based on a phase 2 trial that demonstrated superior recanalization and improved 3-month outcome relative to alteplase. Ongoing randomized phase 3 trials may better define the comparative risks and benefits of tenecteplase and alteplase for stroke thrombolysis and answer questions of tenecteplase efficacy in the >4.5-hour time window, in wake-up stroke, and in combination with endovascular thrombectomy.

scholarly journals PSVI-3 Dietary supplementation with coated omega-3 fatty acids has positive effects on growth performance and nutrients digestibility in weaned pigs

2020 ◽  
Vol 98 (Supplement_3) ◽  
pp. 196-197
Author(s):  
Woo Jung Seok ◽  
Je min Ahn ◽  
Jing Hu ◽  
Dexin Dang ◽  
Yanjiao Li ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Growth Performance ◽  
Phase 1 ◽  
Dietary Supplementation ◽  
Basal Diet ◽  
Phase 2 ◽  
Omega 3 ◽  
Phase 3 ◽  
Linear Effect ◽  
Weaning Pigs

Abstract The objective of this study was to evaluate the effects of dietary supplementation of coated omega-3 fatty acid (n-3 CFA) by corn cob power silica on performance of weaning pigs. A total of 200 weaned pigs [(Landrace x Yorkshire) x Duroc, average initial body weight at 6.97 ± 1.22 kg] were randomly assigned to four experimental treatments in a 6-week experiment in 3 phases as follows: CON, basal diet; 2) 0.3CFA, CON + phase 1(0.3% n-3CFA), phase 2(0.2% n-3CFA), phase 3(0.1% n-3CFA); 3) 0.6CFA, CON + phase 1(0.6% n-3CFA), phase 2(0.4% n-3CFA), phase 3(0.2% n-3CFA); 4) 0.9CFA, CON + phase 1(0.9% n-3CFA), phase 2(0.6% n-3CFA), phase 3 (0.3% n-3CFA). Each treatment had 10 replicates with 5 pigs (three gilts and two barrows) per replicate. The data were analyzed using the GLM procedure of SAS as a randomized complete block design. Pen served as the experimental unit. Linear, quadratic and cubic polynomial contrasts were used to examine effect of dietary treatment with coated n-3FA in the basal diet. Variability in the data was expressed as the standard error of means and P&lt; 0.05 was considered to statistically significant. Increasing the level of n-3CFA in the diet linearly increased ADG and G/F of pigs (Table 1). Increasing the level of n-3CFA showed a linear increment in the digestibility of DM (83.59, 84.38, 85.13, 85.89 %) whereas nitrogen digestibility (81.79, 82.38, 82.96, 83.64 %) showed a trend (linear effect, p=0.0594) at the end of experiment. The fecal lactobacillus count was increased (7.22, 7.27, 7.33, 7.35 log10cfu/g) with the increase in the supplemental level of n-3CFA (linear effect; p&lt; 0.05). However, there were no differences in the concentration of serum haptoglobin, or fecal E. coli, Clostridium and Salmonella counts despite the increase in n-3CFA levels in the diet. Supplementation of the diet with coated n-3 fatty acids positively affected growth performance and digestibility of dry matter and nitrogen, and enhanced the count of lactobacillus in weaning pigs.

scholarly journals Dietary Inclusion of Blood Plasma with Yeast (Saccharomyces cerevisiae) Supplementation Enhanced the Growth Performance, Nutrient Digestibility, Lactobacillus Count, and Reduced Gas Emissions in Weaning Pigs

Animals ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 759
Author(s):  
Vetriselvi Sampath ◽  
Dong Heon Baek ◽  
Sureshkumar Shanmugam ◽  
In Ho Kim
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Phase 1 ◽  
Average Daily Gain ◽  
Nutrient Digestibility ◽  
Phase 2 ◽  
Phase 3 ◽  
Yeast Saccharomyces Cerevisiae ◽  
Yeast Phase ◽  
Weaning Pigs ◽  
Daily Gain

This experiment was performed to examine the hypothesis that blood plasma (BP) with yeast (Saccharomyces cerevisiae) supplement in the diet of weaning pigs could provoke the growth performance, nutrient digestibility, fecal microbial, and reduce harmful gas excretion. A total of one hundred and eighty healthy piglets were taken and assigned (complete random blocks) to three dietary treatments as: Phase 1: Treatment (TRT) 1-6% BP; TRT 2-3% BP + 3% yeast; TRT 3-6% yeast. Phase 2: TRT 1-3%; BP., TRT 2-1.5% BP + 1.5% yeast; TRT 3- 3% yeast. Phase 3: TRT 1- Control (CON) (Basal diet); TRT 2- CON; TRT 3- CON for six- weeks. Each treatment had twelve replicates and five (three gilts and two barrows) pigs per pen. Dietary inclusion of BP with yeast supplementation significantly increased the body weight of piglets during phase 2 (p = 0.003) and phase 3 (p = 0.032). In addition, TRT2 group piglets had a significant improvement in average daily gain at the end of each phase and overall (p = 0.047, 0.025, 0.018 and 0.012, respectively). At phase 3, TRT2 group piglets showed a significant improvement on nutrient digestibility of dry matter (p = 0.012) and nitrogen (p = 0.040). The fecal microbiota of TRT2 group piglets showed a tendency to increase the number of Lactobacillus counts at phase 1 (p = 0.07) and phase 2 (p = 0.06) as well as, a significant improvement at phase 3 (p = 0.021). In addition, TRT2 group piglets had trend to decrease NH3 (p = 0.074) and H2S (p = 0.069) during phase 2, and significantly reduced NH3 (p = 0.038) and H2S (p = 0.046) at phase 3. However, the fecal score of piglets remains unaffected during the entire trial. At the end of phase 1 piglets’ IgG (p = 0.008) was significantly increased with the inclusion of BP with yeast supplementation. Based on the positive effects on body weight, average daily gain, nutrient digestibility, Lactobacillus count, and reduced gas emission, we suggest that dietary supplement with BP and yeast in the diet of weaned piglet could serve as an excellent alternative to antibiotics growth promoters.

Sign in / Sign up

Export Citation Format

Share Document